Analysis
Pharmaceutical research and development: what do we get for all that money?
BMJ 2012; 345 doi: https://doi.org/10.1136/bmj.e4348 (Published 07 August 2012) Cite this as: BMJ 2012;345:e4348
Related articles
- Analysis Published: 07 August 2012; BMJ 345 doi:10.1136/bmj.e4261
- PAPERS Published: 02 September 2005; BMJ doi:10.1136/bmj.38582.703866.AE
- Paper Published: 06 October 2005; BMJ 331 doi:10.1136/bmj.38582.703866.AE
- Education And Debate Published: 20 October 2005; BMJ 331 doi:10.1136/bmj.331.7522.958
- Letter Published: 04 September 2012; BMJ 345 doi:10.1136/bmj.e5880
- Feature Published: 17 February 2014; BMJ 348 doi:10.1136/bmj.g1533
- Editorial Published: 16 March 2018; BMJ 360 doi:10.1136/bmj.k1088
See more
- US Supreme Court ends New York’s restriction on carrying firearms as Senate passes gun regulationsBMJ June 24, 2022, 377 o1563; DOI: https://doi.org/10.1136/bmj.o1563
- The evidence base for US joint commission hospital accreditation standards: cross sectional studyBMJ June 23, 2022, 377 e063064; DOI: https://doi.org/10.1136/bmj-2020-063064
- Political environment and mortality rates in the United States, 2001-19: population based cross sectional analysisBMJ June 07, 2022, 377 e069308; DOI: https://doi.org/10.1136/bmj-2021-069308
- Politics and mortality in the United StatesBMJ June 07, 2022, 377 o1308; DOI: https://doi.org/10.1136/bmj.o1308
- The sickening toll of US gun violence continues to riseBMJ May 31, 2022, 377 o1372; DOI: https://doi.org/10.1136/bmj.o1372
Cited by...
- FDA and EMA clinical research guidelines: Assessment of trial design recommendations for pivotal psychiatric drug trials (Protocol)
- Trump blames free riding foreign states for high US drug prices
- Does Increased Spending on Pharmaceutical Marketing Inhibit Pioneering Innovation?
- Why the drug development pipeline is not delivering better medicines
- Why do cancer drugs get such an easy ride?
- Industry sponsorship bias in research findings: a network meta-analysis of LDL cholesterol reduction in randomised trials of statins
- Patent wars: affordable medicines versus intellectual property rights
- Introduction
- NICE is dead; long live NICE
- Medicine In The Thrall Of The Culture Of Drugs
- Drug development: Innovation or imitation deficit?